Bernstein Cuts Carl Zeiss Meditec Rating After Profit Warning, Lowers Price Target
Bernstein downgraded Carl Zeiss Meditec from Outperform to Market Perform and lowered its price target to EUR31.00 from EUR50.55 following a profit warning and the recent exit of CEO Maximillian Foerst. The firm flagged a sharp year-over-year margin decline and regional pressures in the Americas and China. Goldman Sachs also reduced its rating to N…